IsoPSA Reduces Provider Recommendations for Biopsy and MRI in Men With Total PSA ≥ 4 ng/mL: A Real-World Observational Clinical Utility Study

2021 ◽  
Author(s):  
Jason M. Scovell ◽  
Daniel Hettel ◽  
Robert Abouassaly ◽  
Nima Almasi ◽  
Ryan Berglund ◽  
...  
Keyword(s):  
Real World ◽  
Clinical Utility ◽  
Total Psa

scholarly journals Anaphylaxis and Clinical Utility of Real-World Measurement of Acute Serum Tryptase in UK Emergency Departments

2017 ◽  
Vol 5 (5) ◽  
pp. 1280-1287.e2 ◽  
Author(s):  
Richard J. Buka ◽  
Rebecca C. Knibb ◽  
Richard J. Crossman ◽  
Cathryn L. Melchior ◽  
Aarnoud P. Huissoon ◽  
...  
Keyword(s):  
Real World ◽  
Emergency Departments ◽  
Clinical Utility ◽  
Serum Tryptase

CLINICAL UTILITY OF FREE PSA PERCENT FOR DETECTION OF PROSTATE CANCER IN RELATION TO TOTAL PSA, AGE, AND GLAND VOLUME

1999 ◽  
pp. 319
Author(s):  
Curtis J. Mettlin ◽  
Gerald P. Murphy ◽  
Arthur E. Chesley ◽  
Georg Bartsch ◽  
Ants Toi ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Clinical Utility ◽  
Gland Volume ◽  
Free Psa ◽  
Total Psa

Real-world experience and clinical utility of a non-invasive gene expression rule-out test for melanoma and additional validation against high risk driver mutations in BRAF, NRAS and the TERT promoter

2018 ◽  
Vol 2 ◽  
pp. S69
Author(s):  
Laura Ferris ◽  
Burkhard Jansen ◽  
Zuxu Yao ◽  
Jim Rock ◽  
Maral Skelsey ◽  
...  
Keyword(s):  
Gene Expression ◽  
High Risk ◽  
Real World ◽  
Clinical Utility ◽  
Driver Mutations ◽  
Non Invasive ◽  
Tert Promoter ◽  
Rule Out

Abstract not available. Disclosures: Study sponsored by Dermtech. Copyright 2018 SKIN

Sign in / Sign up

Export Citation Format

Share Document